Cargando…
A multicenter randomized controlled trial to assess the efficacy of cancer green therapy in treatment of stage IIIb/IV non-small cell lung cancer
BACKGROUND: Chemotherapy is the main therapy for stage IIIB/IV non-small cell lung cancer (NSCLC). However, the 5-year survival rate is 6%. Cancer Green Therapy is a novel therapy in China, which refers to cryoablation combined with traditional Chinese medicine (TCM) formula. Our previous retrospect...
Autores principales: | Sun, Manqiang, Zhou, Tian, Fang, Xueni, Wang, Dan, Pang, Haoyue, Chen, Yu, Hu, Kaiwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437773/ https://www.ncbi.nlm.nih.gov/pubmed/32872022 http://dx.doi.org/10.1097/MD.0000000000021626 |
Ejemplares similares
-
Compound Kushen injection plus platinum-based chemotherapy for stage IIIB/IV non-small cell lung cancer: A protocol for meta-analysis of randomized clinical trials following the PRISMA guidelines
por: Chen, Hongwei, et al.
Publicado: (2019) -
Network pharmacology dissection of multiscale mechanisms of herbal medicines in stage IV gastric adenocarcinoma treatment
por: Gao, Li, et al.
Publicado: (2016) -
Effect of Yiqi Huayu Jiedu decoction on stages II and III gastric cancer: A multicenter, prospective, cohort study
por: Shu, Peng, et al.
Publicado: (2019) -
The efficacy and safety of modified Gegenqinlian Fomular for advanced colorectal cancer (damp heat accumulation type): A multicenter randomized controlled trial
por: Wang, Zhi-Jie, et al.
Publicado: (2021) -
Efficacy and safety of acupuncture on oligomenorrhea due to polycystic ovary syndrome: An international multicenter, pilot randomized controlled trial
por: Park, Kyoung Sun, et al.
Publicado: (2022)